- Home
- NMRA vs TRNS Comparison
NMRA vs TRNS Comparison
Compare NMRA & TRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMRA | TRNS |
|---|---|---|
| Founded | 2019 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Electrical Products |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 576.1M | 542.9M |
| IPO Year | 2023 | 1995 |
Fundamental Metrics
Financial Performance| Metric | NMRA | TRNS |
|---|---|---|
| Price | $3.07 | $70.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | $8.00 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 1.7M | 152.7K |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.85 | N/A |
| EPS | N/A | ★ 0.37 |
| Revenue | N/A | ★ $278,421,000.00 |
| Revenue This Year | N/A | $21.75 |
| Revenue Next Year | N/A | $7.55 |
| P/E Ratio | ★ N/A | $203.30 |
| Revenue Growth | N/A | ★ 7.30 |
| 52 Week Low | $0.62 | $50.23 |
| 52 Week High | $3.65 | $97.08 |
Technical Indicators
Market Signals| Indicator | NMRA | TRNS |
|---|---|---|
| Relative Strength Index (RSI) | 53.82 | 43.46 |
| Support Level | $1.53 | $56.95 |
| Resistance Level | $3.25 | $80.98 |
| Average True Range (ATR) | 0.22 | 3.12 |
| MACD | -0.08 | -1.07 |
| Stochastic Oscillator | 32.58 | 4.36 |
Price Performance
Historical ComparisonAbout NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About TRNS Transcat Inc.
Transcat Inc is involved in providing calibration and laboratory instrument services and the distribution of test, measurement, and control instrumentation. The product and services portfolio of the company consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, and others. The firm has Service and Distribution operating segments. The company derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Extech, FLIR, Fluke, Keysight, Megger, and others.